Results 111 to 120 of about 56,983 (273)

Development of an immunoprecipitation assay for detecting anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase autoantibodies using a non‐radioactive biotinylated recombinant protein

Clinical and Experimental Neuroimmunology, EarlyView.
Principle and performance of an immunoprecipitation assay for detecting anti‐3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) autoantibodies using a non‐radioactive biotinylated recombinant protein. This new assay can serve as a potential alternative to the gold standard immunoprecipitation assay for detecting anti‐anti‐3‐hydroxy‐3 ...
Yukihiro Nishikawa, Kimiko Hasegawa, Hiroki Abe, Shun Matsuzawa, Takuya Isayama, Ran Nakashima, Yoshihiko Saito, Ichizo Nishino, Masataka Kuwana   +8 more
wiley   +1 more source

Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry

Clinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background The study objective was to compare the effectiveness of adalimumab (ADA) in monotherapy and in combination with methotrexate (MTX) for paediatric noninfectious uveitis (NIU). Methods Registry‐based observational study. Children receiving ADA for active uveitis were divided into the ADA monotherapy group (group 1) and the ADA plus ...
Carla Gaggiano, Alejandra de‐la‐Torre, Silvana Guerriero, Stefania Costi, Gaafar Ragab, Maria Pia Paroli, Emanuela Del Giudice, Luciana Breda, Saverio La Bella, Marco Cattalini, Maria Cristina Maggio, Alex Fonollosa, Ester Carreño, Maria Tarsia, Rosanna Dammacco, Soad Hashad, Antonio Vitale, Lampros Fotis, Stefano Gentileschi, Francesca Minoia, Germán Mejía‐Salgado, Halah Etayari, Paola Saboya‐Galindo, María Andrea Bernal‐Valencia, Adele Civino, Maria Sole Chimenti, Valeria Caggiano, Maria Francesca Gicchino, Jurgen Sota, Angela Mauro, Giuseppe Lopalco, Kalpana Babu Murthy, Mohamed Tharwat Hegazy, Vishali Gupta, Francesco La Torre, Rana Hussein Amin, Bruno Frediani, Gian Marco Tosi, Luca Cantarini, Claudia Fabiani, on behalf of the AIDA Network   +40 more
wiley   +1 more source

A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers

Arthritis Research & Therapy, 2019
Background To determine the effect of riociguat, an oral, selective soluble guanylate cyclase stimulator, on the net digital ulcer (DU) burden in systemic sclerosis (SSc).
Vivek Nagaraja, Cathie Spino, Erica Bush, Pei-Suen Tsou, Robyn T. Domsic, Robert Lafyatis, Tracy Frech, Jessica K. Gordon, Virginia D. Steen, Dinesh Khanna   +9 more
doaj   +1 more source

Systemic scleroderma.

The Medical clinics of North America, 2020
Jennyy Sun, Gillian Lieberman, Jennyy Sun, Gillian Liberman   +3 more
semanticscholar   +1 more source

Examination of Autoantibody Status and Clinical Features Associated With Cancer Risk and Cancer‐Associated Scleroderma

Arthritis & Rheumatology, 2015
We previously reported a contemporaneous onset of cancer and scleroderma in patients with anti–RNA polymerase III antibodies, and we identified a biologic link between cancer and scleroderma.
Ami A. Shah, L. Hummers, L. Casciola-Rosen, K. Visvanathan, A. Rosen, F. Wigley   +5 more
semanticscholar   +1 more source

NETosis: A bridge between cancer and autoimmunity

Rheumatology &Autoimmunity, EarlyView.
Niloufar Orooji, Manouchehr Fadaee
wiley   +1 more source

Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl, Henning Schliephake, Simon Storgård Jensen   +2 more
wiley   +1 more source

Challenges in management of a patient with oropharyngeal carcinoma and scleroderma

Otolaryngology Case Reports, 2020
Objective: To discuss some of the challenges that can arise in the treatment of patients with oropharyngeal carcinoma and scleroderma, by presenting an illustrative case.
Nicole C. Schmitt, Jeremy Richmon, Harry Quon, Virginia Steen, Kristine Pietsch, Brandi R. Page   +5 more
doaj  

Protocol for a partially nested randomized controlled trial to evaluate the effectiveness of the Scleroderma Patient-centered Intervention Network Support Group Leader EDucation (SPIN-SSLED) Program

Trials, 2019
Background Some people with rare diseases rely on peer-led support groups for disease-specific education and emotional and practical support. Systemic sclerosis (SSc), or scleroderma, is a rare autoimmune connective tissue disease.
Brett D. Thombs, Kylene Aguila, Laura Dyas, Marie-Eve Carrier, Claire Fedoruk, Linda Horwood, Mara Cañedo-Ayala, Maureen Sauvé, Linda Kwakkenbos, Vanessa L. Malcarne, Ghassan El-Baalbaki, Sandra Peláez, Kerri Connolly, Marie Hudson, Robert W. Platt, SPIN-SSLED Support Group Advisory Team   +15 more
doaj   +1 more source

Characterization of Incident Interstitial Lung Disease in Late Systemic Sclerosis. [PDF]

Arthritis Rheumatol
Objective Interstitial lung disease (ILD) is a common and potentially lethal complication of systemic sclerosis (SSc). Screening by high‐resolution computed tomography (HRCT) is recommended in all patients with risk factors, including early disease. Little is known on late presentations of ILD.
Hoa S, Berger C, Lahmek N, Larché M, Osman M, Choi M, Pope J, Thorne C, Canadian Scleroderma Research Group, Hudson M.   +9 more
europepmc   +2 more sources